| Name | Title | Contact Details |
|---|
Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.
The Greater Hudson Valley Health System is dedicated to developing specialty services, medical programs and needed healthcare services that allow residents to remain close to home to receive quality care.
MVNA serves individuals and families that are economically disadvantaged and at high risk for critical social and health issues. More than 90% of MVNA clients residing in Minneapolis are living at or below 200% of Federal Poverty Guidelines. Many of
Medfusion, a Cary, NC-based company offers patient-provider communication solutions nationally to enable healthcare providers offer superior service to their patients while improving office efficiency and generating revenue.
ODA Primary Health Care Center is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.